Whole Foods to Stop Use of Plastic Bags
| |||||||||||||||||||||||
| |||||||||||||||||||||||
| |||||||||||||||||||||||
| |||||||||||||||||||||||
| |||||||||||||||||||||||
Evolving A Drug Free Environment In Your Workplace
Your AMAZINES.COM Subscription Article
(Article Abstract)
Exercise For Back Pain
by Francis Adam
Get up and at 'em. British researchers analyzed the results of 10 studies in which a total of 3,222 people with back pain were advised to either get bed rest or stay active. None of the studies found any benefit in bed rest. In fact, the people who stayed in bed recovered more slowly than those who didn't. After a back injury, y...
Full Article Text:
http://www.amazines.com/article_detail.cfm/411302?articleid=411302&em=1&title=Exercise%2CFor%2CBa
Squatting Works
by Subhash Rao
Why squatting works ! My objective in producing this article is to provide information related to the natural practice of squatting to eliminate. <P>
In India, Africa, China, Far East countries, and Japan (two thirds of the world's population) the vast majority of the population squat to eliminate. Although these cultures ...
Full Article Text:
http://www.amazines.com/article_detail.cfm/409298?articleid=409298&em=1&title=Squatting%2CWorks
Delta Sleep, Deep Space and the Memory Foam Mattress
by Lee D
With nearly 1 million UK residents and all of 70 million US residents seeking help for sleep problems every year, our public roads, schools and workplaces are full of people feeling irritable, groggy or depressed because they simply aren't getting the rest they need. If someone you care for has chronic sleep complaints, the gift...
Full Article Text:
http://www.amazines.com/article_detail.cfm/409300?articleid=409300&em=1&title=Delta%2CSleep%2C%2CDe
Evolving A Drug Free Environment In Your Workplace
by nate rodnay
A drug-free workplace is a protective workplace. They are linked to drug-free and happier families, school and communities. Working Partners ensures a drug-free and secured environment for everyone and helps the employers and employees work together. They also play a vital role in reducing the drug use and end the social, econom...
Full Article Text:
http://www.amazines.com/article_detail.cfm/409318?articleid=409318&em=1&title=Evolving%2CA%2CDrug
This message was sent to you because you opted to receive articles from AMAZINES.COM. If you would
like to unsubscribe from AMAZINES.COM's article emails, click on the following URL:
http://www.amazines.com/subscriptions.cfm
Nutri-Foods Recalls "Organic Sesame Seeds Natural - Unhulled" Because of Possible Health Risk (Feb. 15)
Nutri-Foods Recalls "Organic Sesame Seeds Natural - Unhulled" Because of Possible Health Risk (Feb. 15)
Fri, 15 Feb 2008 16:12:00 -0600
The product comes in a .50 pound clear plastic package with a product SKU #170 at the top and a "packed on" date of December 28. This product was sold from circa December 15, 2007 through January 28, 2008.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
Rocky Mountain Popcorn Company Issues Recall of Low Fat Caramel Popcorn (in the green bag) 9 oz. (Feb. 11)
Rocky Mountain Popcorn Company Issues Recall of Low Fat Caramel Popcorn (in the green bag) 9 oz. (Feb. 11)
Fri, 15 Feb 2008 15:42:00 -0600
Rocky Mountain Popcorn Company, Centennial, CO is voluntarily initiating a nationwide recall of 1,603 bags of Low Fat Caramel 9 oz. Popcorn (in the green bag). This recall is on the Low Fat variety only. An ingredient in this product has been found to contain a trace amount of tree nuts, which potentially could cause an allergic reaction to any person with a tree nut allergy.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
Dreyer's Issues Voluntary Recall of Slow Churned Light Caramel Delight and Butter Pecan Ice Cream Flavors for Undeclared Pecans (Jan. 22)
Dreyer's Issues Voluntary Recall of Slow Churned Light Caramel Delight and Butter Pecan Ice Cream Flavors for Undeclared Pecans (Jan. 22)
Fri, 15 Feb 2008 15:12:00 -0600
The potentially affected cartons are the 1.75-quart size of Dreyer's Slow Churned Light Caramel Delight and Slow Churned Light Butter Pecan ice cream. The sides of the Slow Churned Light cartons identify the flavor as Caramel Delight, but the carton lids identify it as Butter Pecan. The actual flavor of the ice cream may be Butter Pecan erroneously packaged in Caramel Delightcartons, so Dreyer's is recalling the ice cream to avoid any confusion among consumers who may be allergic to pecans.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
FDA MedWatch - Duragesic 25 mcg/hr (fentanyl transdermal system) Pain Patches - Recall because some patches may have a cut edge
  |
PriCara and Sandoz Inc. announced a nationwide recall of all lots of 25 mcg/hr Duragesic Patches sold in the United States. The product is being recalled because the patches may have a cut along one side of the drug reservoir within the patch which may result in the possible release of fentanyl gel that may expose patients or caregivers directly to fentanyl gel on the skin. Fentanyl is a potent Schedule II opioid medication and exposure to the gel may lead to serious adverse events, including respiratory depression and possible overdose, that may be fatal. Patches with a cut edge should not be used. These recalled patches have expiration dates on or before December 2009 and are all manufactured by ALZA Corporation.
Read the complete 2008 MedWatch Safety Summary, including a link to the FDA Firm Press Release regarding this issue at:
http://www.fda.gov/medwatch/safety/2008/safety08.htm#Duragesic
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
What's New at CBER Update
You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.
Supplement Approval: Yellow Fever Vaccine (YF-Vax) - Updated labeling
Posted: 2/15/2008, Approval Date: 2/12/2008
Vacancy Announcement - Biologist, LMD/DVP/OVRR
Posted: 2/15/2008
Vacancy Announcement - Consumer Safety Officer, MRB/DMPQ/OCBQ
Posted: 2/15/2008
Vacancy Announcement - Interdisciplinary Scientist, MRB/DMPQ/OCBQ
Posted: 2/15/2008
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
PriCara Recalls 25 mcg/hr DURAGESIC (fentanyl transdermal system) CII Pain Patches (Feb. 12)
PriCara Recalls 25 mcg/hr DURAGESIC (fentanyl transdermal system) CII Pain Patches (Feb. 12)
Fri, 15 Feb 2008 12:02:00 -0600
PriCara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. said today that all lots of 25 microgram/hour (mcg/hr) DURAGESIC (fentanyl transdermal system) CII patches sold by PriCara in the United States and all 25 mcg/hr fentanyl patches sold by Sandoz Inc. in the United States are being voluntarily recalled as a precaution from wholesalers and pharmacies. The recalled patches all have expiration dates on or before December 2009, and all are manufactured by ALZA Corporation, an affiliate of PriCara. The recall is being conducted in cooperation with the U.S. Food and Drug Administration. All 25 mcg/hr fentanyl patches manufactured by ALZA and sold in Canada also are being recalled.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
Sherwood Brands Announces Nationwide Recall of Pokemon Branded Valentine Cards and Pops Because They May Contain Metal Fragments (Feb. 14)
Sherwood Brands Announces Nationwide Recall of Pokemon Branded Valentine Cards and Pops Because They May Contain Metal Fragments (Feb. 14)
Fri, 15 Feb 2008 12:02:00 -0600
Sherwood Brands LLC is voluntarily recalling approximately 400,000 packages of Pokemon branded "Valentine Cards and Pops" (Item# 073964209109 and Item# 073964289804), because of reports that metal fragments were found in two lollipops purchased in Florida. There are no reports of injury. People who bite into or swallow a metal fragment could possibly be injured.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
FDA Proposes Guidance for Dissemination of Information on Unapproved Uses of Medical Products
FDA Proposes Guidance for Dissemination of Information on Unapproved Uses of Medical Products
Fri, 15 Feb 2008 13:09:00 -0600
The U.S. Food and Drug Administration (FDA) today issued draft guidance on "Good Reprint Practices" for industry use in the distribution of medical or scientific journal articles and reference publications that involve unapproved uses of FDA-approved drugs and medical devices.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
January 2008 Epi-Log Newsletter
You are subscribed to Epi-Log Newsletter for Public Health - Seattle & King County.
The January 2008 issue of the Epi-Log newsletter is now available online at http://www.metrokc.gov/health/epilog/vol4801.htm
Key topics in this issue:
- You Know It’s Pertussis—Now What Do You Do? Management, Treatment, and Prevention of Pertussis
- Chlamydophila psittaci in Birds Sold in the U.S.
- Influenza Monthly Update
- Reported Cases of Selected Diseases in Seattle and King County
# # #
You can update or cancel your subscription at any time by clicking here. All you will need are your e-mail address and your password (if you have selected one).
This service is provided free of charge by: Public Health - Seattle & King County.
P.S. If you have any questions or problems with the subscription service e-mail support@govdelivery.com for assistance. All other inquiries can be directed to publichealth@kingcounty.gov.
GovDelivery, Inc. sending on behalf of Public Health - Seattle & King County. 380 Jackson Street Suite 550, St. Paul, MN 55101. 1-800-439-1420
CDRH New Update
    |
| FDA Home Page | CDRH Home Page | Search | A-Z Index |  | |
 | ||
 | Date: February 15, 2008 |
The following new items were added to the CDRH web pages on February 14, 2008. Previous CDRH New Items can be found on the CDRHNew Page.
 | Draft Guidance for Industry and FDA Staff: Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Influenza Viruses |  |  |
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
CDER New 2/14/2008
| ||||||||||||
February 14, 2008
- Guidance for Industry: Safety Testing of Drug Metabolites [PDF] or [HTML]
- Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies
- New and Generic Drug Approvals
- Abreva (docosanol) Cream, GlaxoSmithKline, Manufacturing Change or Addition
- Azithromycin Tablets, Wockhardt, Approval
- Bicalutamide Tablets, Sandoz Inc., Tentative Approval
- Divalproex Sodium Delayed-release Tablets, Sun Pharma, Tentative Approval
- Doryx (doxycycline hyclate) Delayed-Release Capsules, Warner Chilcott, Labeling Revision
- Duragesic (fentanyl) Transdermal System, Alza Corp., Labeling Revision
- Effexor XR (venlafaxine HCl) Extended Release Capsules, Wyeth Pharma, Labeling Revision
- Effexor (venlafaxine HCl) Immediate Release, Wyeth Pharma, Labeling Revision
- FENTORA (fentanyl buccal) Tablet, Cephalon Inc., Labeling Revision
- Finasteride Tablets, Actavis, Tentative Approval
- Hydrochlorothiazide Capsules, Cadista Pharma, Approval
- Hydrocodone Bitartrate and Homatropine Methylbromide Syrup, Hi-Tech Pharmacal, Approval
- Levalbuterol Hydrochloride Inhalation Solution, Dey, Tentative Approval
- Norflex (Orphenadrine Citrate) Injection, Graceway Pharma, Labeling Revision
- Pravastatin Sodium Tablets, Lek Pharma, Approval
- Propoxyphene Napsylate and Acetaminophen Tablets, Concord Labs, Approval
- Unithroid (levothyroxine sodium) Tablets, Jerome Stevens Pharma, Formulation Revision
- VESIcare (solifenacin succinate) Tablets, Astellas Pharma, Labeling Revision
- Vytorin (ezetimibe/simvastatin) Tablets, Merck & Co., Labeling Revision
- Zetia (Ezetimibe) Tablets, Schering Corp., Labeling Revision
U.S. Food and Drug Administration
Center for Drug Evaluation and Research
1-888-INFO-FDA (1-888-463-6332)
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
Subscribe to:
Posts (Atom)
